Stock ScreenerStock IdeasBiotech BreakthroughsBest Biotech Stocks To Buy NowTop biotech stocks that analysts expect to be profitable within the next 3 years
Stock ScreenerStock IdeasBiotech Breakthroughs
Industry: Biotechnology
Forecast Earnings Growth: Positive
| Ticker | Company | Zen Rating | Price | Value | Graham Fair Value | Graham Fair Value % | P/E | Forward P/E | P/S | P/B | PEG | Free Cash Flow | Free Cash Flow Yield | Book Value | BVPS | EV | EV/EBITDA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| LQDA | LIQUIDIA CORP | $90.22 | $17.14 | 426.30% | 375.92x | 27.15x | 27.56x | 73.89x | 1.82x | $41.15M | 0.52% | $108.58M | 1.23 | $7.98B | 149.00 | ||
| CORT | CORCEPT THERAPEUTICS INC | $110.77 | $24.66 | 349.23% | 209.00x | 189.87x | 14.05x | 16.97x | 1.62x | $106.92M | 0.92% | $705.78M | 6.70 | $11.87B | 1,513.38 | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | $219.20 | $95.06 | 130.58% | 35.93x | 30.26x | 6.10x | 21.66x | 1.09x | $793.95M | 2.71% | $1.35B | 10.14 | $30.61B | 25.95 | ||
| ARQT | ARCUTIS BIOTHERAPEUTICS INC | $25.29 | $8.34 | 203.06% | 120.43x | 157.18x | 7.11x | 14.41x | 1.12x | $39.15M | 1.19% | $220.58M | 1.69 | $3.26B | 71.78 | ||
| KNSA | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | $76.06 | $16.50 | 360.90% | 71.08x | 60.41x | 7.02x | 9.07x | 2.20x | $182.84M | 3.10% | $654.15M | 8.43 | $5.77B | 48.08 | ||
| RPRX | ROYALTY PHARMA PLC | $56.77 | $38.70 | 46.70% | 30.20x | 10.58x | 9.96x | 3.34x | 0.62x | $2.92B | 11.57% | $9.79B | 21.99 | $40.79B | 34.69 | ||
| ASND | ASCENDIS PHARMA A | $255.41 | $76.61 | 233.39% | 27.07x | 17.56x | 15.57x | 27.63x | 2.82x | $52.94M | 0.33% | $574.09M | 9.24 | $16.24B | 174.20 | ||
| KRYS | KRYSTAL BIOTECH INC | $326.45 | $86.77 | 276.21% | 39.47x | 42.81x | 21.88x | 7.11x | 2.33x | $257.78M | 2.67% | $1.36B | 46.03 | $9.24B | 39.62 | ||
| HALO | HALOZYME THERAPEUTICS INC | $103.12 | $71.22 | 44.79% | 28.97x | 12.42x | 7.27x | 81.54x | 0.62x | $806.22M | 6.67% | $143.54M | 1.22 | $13.69B | 19.05 | ||
| VCEL | VERICEL CORP | $45.09 | $8.93 | 404.78% | 93.94x | 93.53x | 7.52x | 6.24x | 2.22x | $61.66M | 2.68% | $370.04M | 7.25 | $2.28B | 51.67 | ||
| ADMA | ADMA BIOLOGICS INC | $9.90 | $8.78 | 12.79% | 13.75x | 11.80x | 4.41x | 5.43x | 0.62x | $116.47M | 5.15% | $408.21M | 1.79 | $2.28B | 9.78 | ||
| LGND | LIGAND PHARMACEUTICALS INC | $293.15 | $97.85 | 199.58% | 37.11x | 31.72x | 21.24x | 5.89x | 1.62x | $122.22M | 2.10% | $997.32M | 50.16 | $6.21B | 27.54 | ||
| BMRN | BIOMARIN PHARMACEUTICAL INC | $63.81 | $21.34 | 199.07% | 167.92x | 17.18x | 3.62x | 1.95x | 1.06x | $738.18M | 5.98% | $6.32B | 32.68 | $15.66B | 40.61 | ||
| ZVRA | ZEVRA THERAPEUTICS INC | $11.56 | $9.49 | 21.84% | 12.17x | 11.16x | 5.03x | 3.15x | 0.79x | $82.01M | 11.99% | $217.65M | 3.68 | $542.65M | 7.02 | ||
| NAGE | NIAGEN BIOSCIENCE INC | $3.12 | $2.25 | 38.79% | 15.60x | 13.49x | 1.92x | 2.99x | 0.81x | $5.67M | 2.31% | $82.53M | 1.04 | $182.46M | 9.76 | ||
| TGTX | TG THERAPEUTICS INC | $49.76 | $23.97 | 107.62% | 16.16x | 35.31x | 8.82x | 12.61x | 1.89x | $17.39M | 0.25% | $604.08M | 4.26 | $7.89B | 56.64 | ||
| JAZZ | JAZZ PHARMACEUTICALS PLC | $256.56 | $195.74 | 31.07% | 16.81x | 9.94x | 3.52x | 3.47x | 0.69x | $1.62B | 9.99% | $4.80B | 75.98 | $19.43B | 12.02 | ||
| TECH | BIO-TECHNE CORP | $72.29 | $16.02 | 351.36% | 101.82x | 34.65x | 9.33x | 5.43x | 1.87x | $269.60M | 2.39% | $2.09B | 13.34 | $11.40B | 44.53 | ||
| MDXG | MIMEDX GROUP INC | $4.34 | $1.11 | 290.28% | 108.50x | -38.68x | 1.81x | 2.93x | 1.53x | $44.50M | 6.94% | $216.00M | 1.46 | $513.97M | 22.53 | ||
| SPRO | SPERO THERAPEUTICS INC | $1.26 | $8.59 | -85.32% | 4.67x | -4.26x | 1.18x | 1.38x | 0.06x | $7.24M | 10.00% | $52.93M | 0.92 | $19.30M | 1.25 | ||
| REGN | REGENERON PHARMACEUTICALS INC | $784.36 | $416.55 | 88.30% | 18.70x | 16.80x | 5.19x | 2.55x | 1.23x | $3.76B | 4.66% | $31.71B | 308.48 | $81.00B | 14.09 | ||
| UTHR | UNITED THERAPEUTICS CORP | $538.84 | $224.45 | 140.07% | 17.82x | 19.69x | 7.28x | 20.63x | 2.40x | $1.09B | 4.76% | $6.40B | 150.24 | $130.21B | 77.67 | ||
| VRTX | VERTEX PHARMACEUTICALS INC | $496.07 | $157.73 | 214.50% | 28.62x | 25.65x | 10.00x | 6.21x | 2.26x | $3.80B | 3.02% | $20.25B | 79.81 | $121.57B | 22.09 | ||
| EXEL | EXELIXIS INC | $54.07 | $28.54 | 89.45% | 16.43x | 16.80x | 5.57x | 7.27x | 1.45x | $1.17B | 8.65% | $1.84B | 7.35 | $13.28B | 12.21 | ||
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $38.41 | $32.93 | 16.65% | 12.23x | 10.12x | 2.32x | 2.24x | 0.72x | $354.90M | 15.95% | $999.24M | 17.25 | $1.84B | 6.57 | ||
| INCY | INCYTE CORP | $120.56 | $60.41 | 99.56% | 14.85x | 15.86x | 4.15x | 3.85x | 1.99x | $1.92B | 7.95% | $6.34B | 31.66 | $20.49B | 9.91 |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.